Global Point-of-Care Glucose Testing Market Size, Share, Trends & Growth Analysis Report Segmented By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), Application, End User And Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), 2026-2034

Point-of-Care Glucose Testing Market Size Overview

The Point-of-Care Glucose Testing Market size was valued at USD 4.09 Billion in 2025 and is projected to grow from USD 4.31 Billion in 2026 to USD 6.50 Billion by 2034, at a CAGR of 5.26% during the forecast period.

The Point-of-Care Glucose Testing market is witnessing robust growth, driven by the increasing prevalence of diabetes and the rising demand for rapid diagnostic solutions. The World Health Organization estimates that the global prevalence of diabetes has nearly quadrupled since 1980, with approximately 422 million adults living with the condition in 2014. This alarming trend underscores the urgent need for effective glucose monitoring solutions, particularly in point-of-care settings where timely intervention can significantly improve patient outcomes.

Moreover, the convenience and accessibility of point-of-care testing devices are propelling market growth. These devices allow for immediate glucose level assessments, enabling healthcare providers to make informed decisions quickly. The shift towards home healthcare and self-monitoring among patients is also contributing to the demand for point-of-care glucose testing solutions. As patients become more engaged in their health management, the need for user-friendly and efficient testing devices is paramount. Additionally, advancements in technology, such as the integration of digital health solutions and mobile applications, are enhancing the functionality and appeal of point-of-care glucose testing devices.

Market Dynamics

Point-of-Care Glucose Testing Market Drivers

• Rising Prevalence of Diabetes: The increasing prevalence of diabetes is a primary driver for the Point-of-Care Glucose Testing market. According to the International Diabetes Federation, the number of adults with diabetes is projected to rise to 642 million by 2040. This surge in diabetes cases is attributed to various factors, including sedentary lifestyles, unhealthy dietary habits, and an aging population. The growing incidence of diabetes necessitates effective monitoring solutions to manage blood glucose levels and prevent complications associated with the disease. Point-of-care glucose testing devices provide rapid and accurate results, enabling healthcare providers to make timely decisions regarding patient care. As the global diabetes epidemic continues to escalate, the demand for point-of-care glucose testing solutions is expected to grow significantly.
• Technological Advancements: Technological advancements in point-of-care glucose testing devices are significantly influencing market growth. Innovations such as continuous glucose monitoring systems, smart glucose meters, and mobile health applications are enhancing the accuracy and convenience of glucose testing. According to the U.S. Food and Drug Administration, advancements in sensor technology have led to the development of devices that provide real-time glucose monitoring, allowing patients to track their levels continuously. These innovations not only improve patient outcomes but also empower individuals to take control of their health. As technology continues to evolve, the demand for advanced point-of-care glucose testing solutions is expected to rise, driving market expansion.
• Shift Towards Home Healthcare: The shift towards home healthcare is a significant driver for the Point-of-Care Glucose Testing market. With the increasing emphasis on patient-centered care and the desire for convenience, more individuals are opting for home-based monitoring solutions. According to a report by the Centers for Disease Control and Prevention, home glucose monitoring is becoming increasingly popular among patients with diabetes, as it allows for greater flexibility and independence in managing their condition. Point-of-care glucose testing devices are designed for ease of use, enabling patients to perform tests in the comfort of their homes. This trend is further supported by the growing aging population, which often requires ongoing monitoring and management of chronic conditions. As the demand for home healthcare solutions continues to rise, the point-of-care glucose testing market is expected to benefit significantly.
• Government Initiatives and Support: Government initiatives and support for diabetes management and prevention are playing a crucial role in driving the Point-of-Care Glucose Testing market. Many governments worldwide are implementing programs aimed at raising awareness about diabetes and promoting early detection and management. For instance, the Centers for Disease Control and Prevention has launched initiatives to improve diabetes care and encourage regular glucose monitoring among at-risk populations. These efforts not only enhance public awareness but also facilitate access to point-of-care testing solutions. Additionally, government funding and support for research and development in diabetes care are fostering innovation in the market. As governments continue to prioritize diabetes management, the demand for point-of-care glucose testing devices is expected to grow.

Point-of-Care Glucose Testing Market Opportunities

• Expansion of Telehealth Services: The expansion of telehealth services presents a significant opportunity for the Point-of-Care Glucose Testing market. The COVID-19 pandemic has accelerated the adoption of telehealth, allowing patients to receive medical consultations remotely. According to the U.S. Department of Health and Human Services, telehealth visits increased by 154% during the pandemic compared to the previous year. This shift towards virtual healthcare has created a demand for remote monitoring solutions, including point-of-care glucose testing devices. By integrating glucose testing with telehealth platforms, healthcare providers can offer comprehensive care to patients, enabling them to monitor their glucose levels from home while receiving professional guidance. As telehealth continues to gain traction, the point-of-care glucose testing market is well-positioned to capitalize on this opportunity.
• Increasing Health Awareness: The increasing health awareness among consumers is driving the demand for point-of-care glucose testing solutions. As individuals become more informed about the importance of regular health monitoring, there is a growing interest in self-testing devices for diabetes management. According to a survey conducted by the American Diabetes Association, a significant percentage of individuals with diabetes reported a desire to take a more active role in managing their condition. This trend is encouraging manufacturers to develop user-friendly and accurate glucose testing devices that cater to the needs of health-conscious consumers. As awareness of diabetes and its complications continues to rise, the demand for point-of-care glucose testing solutions is expected to grow.
• Rising Incidence of Gestational Diabetes: The rising incidence of gestational diabetes presents a unique opportunity for the Point-of-Care Glucose Testing market. Gestational diabetes affects a significant number of pregnant women, with the Centers for Disease Control and Prevention estimating that approximately 6-9% of pregnancies in the United States are affected by this condition. The need for regular glucose monitoring during pregnancy is crucial for the health of both the mother and the baby. Point-of-care glucose testing devices offer a convenient solution for expectant mothers to monitor their glucose levels effectively. As awareness of gestational diabetes increases and more women seek proactive management, the demand for point-of-care glucose testing solutions is expected to rise.
• Emerging Markets: Emerging markets present a significant growth opportunity for the Point-of-Care Glucose Testing market. As healthcare infrastructure improves in developing regions, there is a growing demand for accessible and affordable diabetes management solutions. According to the World Health Organization, the prevalence of diabetes is rising rapidly in low- and middle-income countries, necessitating effective monitoring solutions. Point-of-care glucose testing devices can provide timely and accurate results, enabling healthcare providers to manage diabetes effectively in these regions. Additionally, the increasing availability of healthcare services and the rising disposable income of consumers in emerging markets are driving the demand for point-of-care glucose testing solutions. As manufacturers expand their presence in these markets, the potential for growth is substantial.

Point-of-Care Glucose Testing Market Restrain & Challenges

• High Cost of Devices: The high cost of point-of-care glucose testing devices poses a significant challenge to market growth. While advancements in technology have led to the development of innovative and accurate testing solutions, these devices can be expensive, making them less accessible to certain populations. According to the American Diabetes Association, the cost of diabetes management can be a burden for many individuals, particularly those without insurance coverage. The financial constraints faced by patients may limit their ability to invest in point-of-care glucose testing devices, hindering market expansion. Manufacturers must find ways to reduce costs and improve affordability to ensure that these essential tools are accessible to all individuals with diabetes.
• Regulatory Challenges: Navigating the regulatory landscape can pose challenges for manufacturers in the Point-of-Care Glucose Testing market. Regulatory requirements for medical devices can vary by region and may involve stringent testing and approval processes. According to the U.S. Food and Drug Administration, point-of-care glucose testing devices must meet specific safety and efficacy standards before they can be marketed. Compliance with these regulations can be time-consuming and costly, potentially delaying the introduction of new products to the market. These regulatory challenges may create barriers for manufacturers, impacting their ability to compete effectively in the market.
• Competition from Alternative Testing Methods: The Point-of-Care Glucose Testing market faces competition from alternative testing methods, such as laboratory-based glucose testing and continuous glucose monitoring systems. While point-of-care testing offers convenience and rapid results, some healthcare providers may prefer laboratory testing for its accuracy and reliability. According to the American Association for Clinical Chemistry, laboratory tests are often considered the gold standard for glucose monitoring. Additionally, continuous glucose monitoring systems provide real-time data and trends, which may appeal to patients seeking comprehensive management of their diabetes. As competition from these alternative methods increases, manufacturers of point-of-care glucose testing devices must differentiate their products and demonstrate their value to healthcare providers and patients.

Current Trends in the Point-of-Care Glucose Testing Market

• Integration of Digital Health Solutions: The integration of digital health solutions into point-of-care glucose testing devices is a significant trend shaping the market. With the rise of mobile health applications and telehealth services, manufacturers are increasingly incorporating digital features into their glucose testing devices. According to a report by the World Health Organization, the use of mobile health technologies has the potential to improve diabetes management by enabling patients to track their glucose levels and share data with healthcare providers. These digital solutions enhance patient engagement and empower individuals to take control of their health. As the demand for connected health solutions continues to grow, the integration of digital health features in point-of-care glucose testing devices is expected to drive market growth.
• Focus on User-Friendly Designs: The focus on user-friendly designs is a prominent trend in the Point-of-Care Glucose Testing market. As more individuals take an active role in managing their diabetes, there is a growing demand for testing devices that are easy to use and require minimal training. Manufacturers are prioritizing ergonomic designs, intuitive interfaces, and simplified testing procedures to enhance the user experience. According to a survey conducted by the American Diabetes Association, patients expressed a preference for glucose testing devices that are straightforward and convenient to use. By developing user-friendly products, manufacturers can improve patient adherence to glucose monitoring and drive demand for point-of-care testing solutions.
• Advancements in Sensor Technology: Advancements in sensor technology are revolutionizing the Point-of-Care Glucose Testing market. Innovations in biosensors and microfluidics are enabling the development of more accurate and reliable glucose testing devices. According to a study published in the Journal of Diabetes Science and Technology, new sensor technologies have the potential to improve the precision of glucose measurements and reduce the risk of errors. These advancements not only enhance the performance of point-of-care glucose testing devices but also contribute to better patient outcomes. As manufacturers continue to invest in research and development, the demand for advanced sensor technologies in glucose testing is expected to rise.
• Emphasis on Preventive Healthcare: The emphasis on preventive healthcare is driving the demand for point-of-care glucose testing solutions. As healthcare systems shift towards a preventive approach, there is a growing recognition of the importance of early detection and management of diabetes. According to the Centers for Disease Control and Prevention, preventive healthcare measures can significantly reduce the incidence of diabetes-related complications. Point-of-care glucose testing devices play a crucial role in facilitating early diagnosis and ongoing monitoring of glucose levels. As healthcare providers prioritize preventive care, the demand for point-of-care glucose testing solutions is expected to grow, contributing to market expansion.

Contact Us

Segmentation Insights

Point-of-Care Glucose Testing Market Analysis, By Product Type

By Product Type, the Point-of-Care Glucose Testing market is categorized into Lancing Devices and Strips and Blood-Glucose Meters.

• The largest segment in the Point-of-Care Glucose Testing market is the Blood-Glucose Meters segment. This segment is leading due to the widespread adoption of blood-glucose meters among individuals with diabetes for self-monitoring purposes. Blood-glucose meters provide accurate and rapid results, allowing patients to manage their glucose levels effectively. The convenience of these devices, combined with their ability to deliver real-time data, makes them a preferred choice for both patients and healthcare providers. As the prevalence of diabetes continues to rise, the demand for blood-glucose meters is expected to remain strong, solidifying its position as the largest segment in the market.
• The fastest-growing segment in the Point-of-Care Glucose Testing market is the Lancing Devices and Strips segment. This segment is experiencing rapid growth due to the increasing awareness of the importance of regular glucose monitoring and the need for efficient testing solutions. Lancing devices and strips are essential components of blood-glucose testing, enabling patients to obtain blood samples for analysis. The growing emphasis on self-monitoring and the convenience of using lancing devices at home are driving the demand for this segment. As more individuals seek to take control of their diabetes management, the Lancing Devices and Strips segment is expected to grow at a faster rate.

Point-of-Care Glucose Testing Market Analysis, By Application

By Application, the Point-of-Care Glucose Testing market is categorized into Type-1 Diabetes and Type-2 Diabetes.

• The largest segment in the Point-of-Care Glucose Testing market is the Type-2 Diabetes segment. This segment is leading due to the higher prevalence of Type-2 diabetes compared to Type-1 diabetes. According to the Centers for Disease Control and Prevention, approximately 90-95% of diabetes cases in adults are classified as Type-2 diabetes. The increasing incidence of Type-2 diabetes, driven by factors such as obesity and sedentary lifestyles, necessitates effective glucose monitoring solutions. Point-of-care glucose testing devices play a crucial role in managing Type-2 diabetes, enabling patients to monitor their glucose levels and make informed decisions regarding their treatment. As the prevalence of Type-2 diabetes continues to rise, the demand for point-of-care glucose testing solutions in this segment is expected to remain strong.
• The fastest-growing segment in the Point-of-Care Glucose Testing market is the Type-1 Diabetes segment. This segment is experiencing rapid growth due to the increasing awareness of Type-1 diabetes and the need for effective management solutions. Type-1 diabetes, which typically develops in childhood or adolescence, requires lifelong insulin therapy and regular glucose monitoring. As awareness of the condition grows and more individuals are diagnosed, the demand for point-of-care glucose testing solutions for Type-1 diabetes is expected to rise. Additionally, advancements in technology and the availability of user-friendly testing devices are contributing to the growth of this segment.

Point-of-Care Glucose Testing Market Analysis, By End User

By End User, the Point-of-Care Glucose Testing market is categorized into Hospitals and Clinics, Home Care Settings, and Others.

• The largest segment in the Point-of-Care Glucose Testing market is the Hospitals and Clinics segment. This segment is leading due to the high volume of diabetes patients seeking care in healthcare facilities. Hospitals and clinics play a crucial role in diabetes management, providing comprehensive care and monitoring for patients. Point-of-care glucose testing devices are essential tools in these settings, enabling healthcare providers to obtain rapid glucose results and make timely treatment decisions. The increasing prevalence of diabetes and the growing emphasis on effective management in healthcare facilities are driving the demand for point-of-care glucose testing solutions in this segment.
• The fastest-growing segment in the Point-of-Care Glucose Testing market is the Home Care Settings segment. This segment is experiencing rapid growth due to the rising trend of home healthcare and self-monitoring among patients. With the increasing emphasis on patient-centered care, more individuals are opting for home-based monitoring solutions to manage their diabetes effectively. Point-of-care glucose testing devices designed for home use offer convenience and flexibility, allowing patients to monitor their glucose levels without frequent visits to healthcare facilities. As the demand for home healthcare solutions continues to rise, the Home Care Settings segment is expected to grow at a faster rate.

Point-of-Care Glucose Testing Market Regional Insights

The market has been geographically analysed across five regions, Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

• The largest region in the Point-of-Care Glucose Testing market is North America. This region is leading due to the high prevalence of diabetes and the well-established healthcare infrastructure. North America is home to a significant number of diabetes patients, and healthcare providers actively promote the use of point-of-care glucose testing devices for effective management. Additionally, the presence of key market players and ongoing research and development activities contribute to the region's dominance in the market. As awareness of diabetes continues to rise and the demand for effective monitoring solutions increases, the Point-of-Care Glucose Testing market in North America is expected to remain strong.
• The fastest-growing region in the Point-of-Care Glucose Testing market is the Asia-Pacific region. This region is experiencing rapid growth due to the increasing prevalence of diabetes and the rising demand for accessible healthcare solutions. According to the International Diabetes Federation, the Asia-Pacific region has one of the highest rates of diabetes prevalence globally. The growing middle-class population, improving healthcare infrastructure, and increasing awareness of diabetes management are driving the demand for point-of-care glucose testing solutions in this region. As healthcare providers expand their services and more individuals seek effective monitoring solutions, the Point-of-Care Glucose Testing market in Asia-Pacific is expected to grow at a faster rate.

Point-of-Care Glucose Testing Market Competitive Overview

The Point-of-Care Glucose Testing market is characterized by a competitive landscape with several key players striving to gain market share. Companies are focusing on product innovation, technological advancements, and strategic partnerships to enhance their offerings and meet the evolving needs of healthcare providers and patients. The market is witnessing an increase in mergers and acquisitions as companies seek to expand their product portfolios and strengthen their market presence. Additionally, the emphasis on quality and compliance with regulatory standards is driving manufacturers to invest in research and development activities. As the demand for point-of-care glucose testing solutions continues to grow, competition among market players is expected to intensify, leading to further advancements in product offerings.

Leading Market Players in the Point-of-Care Glucose Testing Market

• Prodigy Diabetes Care LLC: Prodigy Diabetes Care LLC is a prominent player in the Point-of-Care Glucose Testing market, known for its innovative glucose monitoring solutions. The company specializes in developing user-friendly blood glucose meters and testing devices designed to empower individuals with diabetes to manage their condition effectively. Prodigy’s commitment to quality and accuracy has established it as a trusted brand among healthcare providers and patients alike. The company focuses on continuous improvement and innovation, ensuring that its products meet the evolving needs of the diabetes community.
• Ascensia Diabetes Care Holdings AG: Ascensia Diabetes Care Holdings AG is recognized for its expertise in diabetes management and point-of-care glucose testing solutions. The company offers a range of advanced blood glucose monitoring systems that provide accurate and reliable results for patients. Ascensia is dedicated to improving the lives of people with diabetes through innovative technology and user-friendly designs. The company’s strong emphasis on research and development enables it to stay at the forefront of the diabetes care market, delivering high-quality products that enhance patient outcomes.
• ACON Laboratories, Inc.: ACON Laboratories, Inc. is a key player in the Point-of-Care Glucose Testing market, specializing in the development and manufacturing of diagnostic devices. The company offers a variety of glucose testing solutions, including blood glucose meters and testing strips, designed to provide accurate and timely results for diabetes management. ACON Laboratories is committed to innovation and quality, ensuring that its products meet the highest standards of performance and reliability. The company focuses on making diabetes care accessible and affordable, catering to the needs of both healthcare providers and patients. With a strong presence in the global market, ACON Laboratories continues to expand its product offerings and enhance its technological capabilities to support effective diabetes management.

Top Strategies Followed by Players

• Focus on Research and Development: Leading players in the Point-of-Care Glucose Testing market prioritize research and development as a core strategy to drive innovation and enhance product offerings. By investing in R&D, companies aim to develop advanced glucose monitoring solutions that incorporate the latest technologies, such as continuous glucose monitoring and smart devices. This focus on innovation not only improves the accuracy and reliability of testing devices but also enhances user experience, making it easier for patients to manage their diabetes effectively. As the market evolves, companies that prioritize R&D will be better positioned to meet the changing needs of consumers and healthcare providers.
• Strategic Partnerships and Collaborations: Strategic partnerships and collaborations are essential strategies employed by market players to expand their reach and enhance their product offerings. By partnering with healthcare providers, technology companies, and research institutions, manufacturers can leverage expertise and resources to develop innovative solutions. These collaborations often lead to the creation of integrated healthcare solutions that combine glucose monitoring with telehealth services, enabling patients to receive comprehensive care. Additionally, partnerships with distribution channels can enhance product visibility and accessibility, allowing companies to reach a broader audience. As the demand for point-of-care glucose testing solutions continues to grow, strategic collaborations will play a crucial role in driving market expansion.
• Emphasis on Patient Education and Support: A growing emphasis on patient education and support is shaping the strategies of leading players in the Point-of-Care Glucose Testing market. Companies are increasingly investing in educational initiatives aimed at informing patients about the importance of regular glucose monitoring and effective diabetes management. By providing resources, training, and support, manufacturers can empower individuals to take an active role in managing their health. This focus on education not only helps to improve patient adherence to glucose monitoring but also fosters brand loyalty and trust. As awareness of diabetes and its management continues to rise, companies that prioritize patient education will be well-positioned to succeed in the market.

List of Companies Profiled in the Report are:

• Prodigy Diabetes Care LLC
• Ascensia Diabetes Care Holdings AG
• ACON Laboratories Inc.
• EKF Diagnostics Holdings plc
• Trividia Health Inc.
• Platinum Equity Advisors LLC
• Abbott Laboratories
• Nipro
• F. Hoffmann-La Roche Ltd.
• Nova Biomedical Corporation

Global Point-of-Care Glucose Testing Market Report Scope and Key Segmentation

List of Segments Covered

This section of the Point-of-Care Glucose Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Lancing Devices and Strips
• Blood-Glucose Meter

By Application

• Type-1 Diabetes
• Type-2 Diabetes

By End User

• Hospitals and Clinics
• Home Care Settings
• Others